Chemotherapy for melanoma - why is it not effective and what is its future?
Using biomarkers to predict response to combination therapies in BRAF-mutant melanoma
Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials
Role of BRAF mutation in the treatment for melanoma
Cell cycle-dependent resistance or sensitivity to drugs and the importance of MITF genes in melanoma